Literature DB >> 7559904

Expression of the gene encoding growth hormone in the human mammary gland.

J A Mol1, S C Henzen-Logmans, P Hageman, W Misdorp, M A Blankenstein, A Rijnberk.   

Abstract

Progestins cause a syndrome of growth hormone (GH) excess and enhanced mammary tumorigenesis in the dog. This has been regarded as being specific for the dog. Recently we reported that progestin-induced GH excess originates from foci of hyperplastic ductular epithelium of the mammary gland in the dog. In the present report we demonstrate by reverse-transcriptase PCR and immunohistochemistry that a main factor involved in tissue growth, i.e. GH, is also expressed in normal and neoplastic human mammary glands. The gene expressed in the human mammary gland proved to be identical to the gene encoding GH in the pituitary gland. The role of progesterone in the GH expression of the human mammary gland needs, however, to be proven. It is hypothesized that this locally produced hGH may play a pathogenetic role in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559904     DOI: 10.1210/jcem.80.10.7559904

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone.

Authors:  Svetlana Mukhina; Hichem C Mertani; Ke Guo; Kok-Onn Lee; Peter D Gluckman; Peter E Lobie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-07       Impact factor: 11.205

Review 2.  Growth hormone. A paracrine growth factor?

Authors:  S Harvey; K L Hull
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

3.  Growth hormone receptor is expressed in human breast cancer.

Authors:  M Gebre-Medhin; L G Kindblom; H Wennbo; J Törnell; J M Meis-Kindblom
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

4.  Proteolytic processing of human growth hormone (GH) by rat tissues in vitro: influence of sex and age.

Authors:  M Garcia-Barros; J Devesa; V M Arce
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

5.  Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop.

Authors:  E van Garderen; M de Wit; W F Voorhout; G R Rutteman; J A Mol; H Nederbragt; W Misdorp
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

Review 6.  Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.

Authors:  Eric M Jacobson; Eric R Hugo; Traci R Tuttle; Ruben Papoian; Nira Ben-Jonathan
Journal:  Trends Endocrinol Metab       Date:  2010-09-16       Impact factor: 12.015

Review 7.  Benign breast diseases.

Authors:  Carine Courtillot; Geneviève Plu-Bureau; Nadine Binart; Corinne Balleyguier; Brigitte Sigal-Zafrani; Vincent Goffin; Frédérique Kuttenn; Paul A Kelly; Philippe Touraine
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

Review 8.  The growth hormone receptor: mechanism of activation and clinical implications.

Authors:  Andrew J Brooks; Michael J Waters
Journal:  Nat Rev Endocrinol       Date:  2010-07-27       Impact factor: 43.330

Review 9.  The contribution of growth hormone to mammary neoplasia.

Authors:  Jo K Perry; Kumarasamypet M Mohankumar; B Starling Emerald; Hichem C Mertani; Peter E Lobie
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-07       Impact factor: 2.673

Review 10.  Breast cancer: further metabolic-endocrine risk markers?

Authors:  B A Stoll
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.